Login

Balance Sheets

In millions of USD, except per-share amounts
Q3 FY2022
As of Sep 30, 2022
Q2 FY2022
As of Jun 30, 2022
Q1 FY2022
As of Mar 31, 2022
Q4 FY2021
As of Dec 31, 2021
Q3 FY2021
As of Sep 30, 2021
Q2 FY2021
As of Jun 30, 2021
Q1 FY2021
As of Mar 31, 2021
Q4 FY2020
As of Dec 31, 2020
Q3 FY2020
As of Sep 30, 2020
ASSETS
Deferred offering costs
Current assets
Cash
Prepaid expenses
Other current assets
Total Current Assets
Cash and Marketable Securities held in Trust Account
TOTAL ASSETS
LIABILITIES AND STOCKHOLDERS’ EQUITY
Promissory note - related party
Accrued Expenses
Loan Payable - Related Party
Income Tax Payable
Deferred underwriting fee payable
Warrant liability
Total Liabilities
Class A common stock subject to possible redemption, 2,535,838 and 30,000,000 shares issued and outstanding at redemption value at September 30, 2022 and December 31, 2021, respectively
Stockholders’ Deficit
Class A common stock, $0.0001 par value; 100,000,000 shares authorized; 2,535,838 and 30,000,000 issued and outstanding, subject to redemption at September 30, 2022 and December 31, 2021, respectively
Class A Common Stock
Class B Common Stock
Total class A common stock, $0.0001 par value; 100,000,000 shares authorized; 2,535,838 and 30,000,000 issued and outstanding, subject to redemption at September 30, 2022 and December 31, 2021, respectively
Class B common stock, $0.0001 par value; 10,000,000 shares authorized; 7,500,000 shares issued and outstanding, non-redeemable
Additional paid-in capital
Accumulated deficit
Stockholders’ Equity
Class A Common Stock
Class B Common Stock
Total Stockholders’ Equity
Total Stockholders’ Equity
TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support